Early research (Phase 1)Study completedNCT06372652What this trial is testingTE-8214 Solution in Healthy VolunteersWho this might be right forAcromegaly Immunwork, Inc. 32
Large-scale testing (Phase 3)Study completedNCT01460706What this trial is testingImaging Malignant Glioma With 68Ga-DOTATOC PET/CTWho this might be right forGlioma Turku University Hospital 30
Early research (Phase 1)UnknownNCT03308682What this trial is testing177Lu-DOTA-EB-TATE in Patients With Advanced Neuroendocrine TumorsWho this might be right forNeuroendocrine Tumors Peking Union Medical College Hospital 30
Not applicableStudy completedNCT02152124What this trial is testingGrowth Hormone, IGF-1 and Medical Treatment in Acromegaly: Are There Effects on Gut Hormone Physiology and Postprandial Substrate Metabolism?Who this might be right forAcromegaly University Hospital, Ghent 21
Not applicableStudy completedNCT00703079What this trial is testingImpact of Somatostatin Analogs vs. Surgery on Glucose Metabolism in AcromegalyWho this might be right forAcromegaly Federico II University 100
Not applicableWithdrawnNCT05184231What this trial is testingPatient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in ChinaWho this might be right forAcromegaly Ipsen
Not applicableUnknownNCT03812939What this trial is testingRecurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin AnalogsWho this might be right forGastric NET Peking Union Medical College Hospital 30
Post-approval studies (Phase 4)Study completedNCT03289741What this trial is testingEvaluate Patient Experience in the Therapy of Neuroendocrine Tumors Treated With Octreotide Long Acting Release Versus LanreotideWho this might be right forNeuroendocrine Tumors Memorial Sloan Kettering Cancer Center 51
Early research (Phase 1)UnknownNCT02967666What this trial is testingEvaluation of PET/MRI Using a Somatostatin Analog Tracer as a Novel Approach to Detecting Pathology in High Risk TB-exposed ContactsWho this might be right forTuberculosis, Pulmonary National University Hospital, Singapore 30
Post-approval studies (Phase 4)Study completedNCT01070758What this trial is testingLanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of InfancyWho this might be right forCongenital Hyperinsulinism Sheba Medical Center 3
Large-scale testing (Phase 3)Study completedNCT03000946What this trial is testingPrevention of Postoperative Pancreatic Fistula by SomatostatinWho this might be right forPancreatic Surgery Assistance Publique - Hôpitaux de Paris 655
Early research (Phase 1)UnknownNCT03774680What this trial is testingTargeted Polymeric Nanoparticles Loaded With Cetuximab and Decorated With Somatostatin Analogue to Colon CancerWho this might be right forColon CancerColo-rectal Cancer Ahmed A. H. Abdellatif 30
Not applicableStudy completedNCT00652379What this trial is testingCo-treatment With Pegvisomant and a Somatostatin Analogue (SA) in SA-responsive Acromegalic PatientsWho this might be right forAcromegalyInsulin ResistanceImpaired Glucose Tolerance University of Aarhus 18
Large-scale testing (Phase 3)Study completedNCT02685709What this trial is testingComparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in AcromegalyWho this might be right forAcromegaly Chiasma, Inc. 146
Testing effectiveness (Phase 2)Study completedNCT03789656What this trial is testingEvaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (ACROBAT Edge)Who this might be right forAcromegaly Crinetics Pharmaceuticals Inc. 47
Large-scale testing (Phase 3)Study completedNCT01677910What this trial is testingTELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome)Who this might be right forCarcinoid Syndrome Lexicon Pharmaceuticals 135
Large-scale testing (Phase 3)Study completedNCT00600886What this trial is testingSafety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active AcromegalyWho this might be right forAcromegaly Novartis Pharmaceuticals 358
Testing effectiveness (Phase 2)Study completedNCT02217800What this trial is testingThe Effect of Subcutaneous Infusions of 3 Doses of DG3173 on Growth Hormone Levels in Untreated AcromegalicsWho this might be right forAcromegaly Aspireo Pharmaceuticals Limited 8
Post-approval studies (Phase 4)Study completedNCT00376064What this trial is testingEfficacy of Octreotide Acetate and Cabergoline in Patients With AcromegalyWho this might be right forAcromegaly Novartis Pharmaceuticals 20
Not applicableStudy completedNCT04696042What this trial is testingAsian Investigation of Lanreotide Autogel® in the Management of GEP-NETsWho this might be right forNeuroendocrine Tumors Asan Medical Center 71